240 related articles for article (PubMed ID: 12883358)
1. CD44s adhesive function spontaneous and PMA-inducible CD44 cleavage are regulated at post-translational level in cells of melanocytic lineage.
Gasbarri A; Del Prete F; Girnita L; Martegani MP; Natali PG; Bartolazzi A
Melanoma Res; 2003 Aug; 13(4):325-37. PubMed ID: 12883358
[TBL] [Abstract][Full Text] [Related]
2. Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan.
Bartolazzi A; Nocks A; Aruffo A; Spring F; Stamenkovic I
J Cell Biol; 1996 Mar; 132(6):1199-208. PubMed ID: 8601595
[TBL] [Abstract][Full Text] [Related]
3. CD44: structure, function, and association with the malignant process.
Naor D; Sionov RV; Ish-Shalom D
Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
[TBL] [Abstract][Full Text] [Related]
4. CD44 and variants in melanocytic skin neoplasms.
Schaider H; Soyer HP; Heider KH; Hofmann-Wellenhof R; Zatloukal K; Smolle J; Kerl H
J Cutan Pathol; 1998 Apr; 25(4):199-203. PubMed ID: 9609138
[TBL] [Abstract][Full Text] [Related]
5. Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons.
Bennett KL; Modrell B; Greenfield B; Bartolazzi A; Stamenkovic I; Peach R; Jackson DG; Spring F; Aruffo A
J Cell Biol; 1995 Dec; 131(6 Pt 1):1623-33. PubMed ID: 8522617
[TBL] [Abstract][Full Text] [Related]
6. Migration of highly aggressive melanoma cells on hyaluronic acid is associated with functional changes, increased turnover and shedding of CD44 receptors.
Goebeler M; Kaufmann D; Bröcker EB; Klein CE
J Cell Sci; 1996 Jul; 109 ( Pt 7)():1957-64. PubMed ID: 8832418
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.
Ahrens T; Sleeman JP; Schempp CM; Howells N; Hofmann M; Ponta H; Herrlich P; Simon JC
Oncogene; 2001 Jun; 20(26):3399-408. PubMed ID: 11423990
[TBL] [Abstract][Full Text] [Related]
8. The CD44 receptor of lymphoma cells: structure-function relationships and mechanism of activation.
Rochman M; Moll J; Herrlich P; Wallach SB; Nedvetzki S; Sionov RV; Golan I; Ish-Shalom D; Naor D
Cell Adhes Commun; 2000 Jan; 7(4):331-47. PubMed ID: 10714394
[TBL] [Abstract][Full Text] [Related]
9. Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity.
Sleeman J; Rudy W; Hofmann M; Moll J; Herrlich P; Ponta H
J Cell Biol; 1996 Nov; 135(4):1139-50. PubMed ID: 8922392
[TBL] [Abstract][Full Text] [Related]
10. Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells.
Montero-Montero L; Renart J; Ramírez A; Ramos C; Shamhood M; Jarcovsky R; Quintanilla M; Martín-Villar E
Cells; 2020 Sep; 9(10):. PubMed ID: 33003440
[TBL] [Abstract][Full Text] [Related]
11. Distinct kinetic and molecular requirements govern CD44 binding to hyaluronan versus fibrin(ogen).
Raman PS; Alves CS; Wirtz D; Konstantopoulos K
Biophys J; 2012 Aug; 103(3):415-423. PubMed ID: 22947857
[TBL] [Abstract][Full Text] [Related]
12. CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression.
Bourguignon LY; Zhu D; Zhu H
Front Biosci; 1998 Jul; 3():d637-49. PubMed ID: 9634539
[TBL] [Abstract][Full Text] [Related]
13. Introduction of antisense CD44S CDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells.
Harada N; Mizoi T; Kinouchi M; Hoshi K; Ishii S; Shiiba K; Sasaki I; Matsuno S
Int J Cancer; 2001 Jan; 91(1):67-75. PubMed ID: 11149422
[TBL] [Abstract][Full Text] [Related]
14. Membrane protein glycosylation and CD44 content in the adhesion of human ovarian cancer cells to hyaluronan.
Catterall JB; Jones LM; Turner GA
Clin Exp Metastasis; 1999; 17(7):583-91. PubMed ID: 10845557
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid-CD44 interactions promote BMP4/7-dependent Id1/3 expression in melanoma cells.
Wu RL; Sedlmeier G; Kyjacova L; Schmaus A; Philipp J; Thiele W; Garvalov BK; Sleeman JP
Sci Rep; 2018 Oct; 8(1):14913. PubMed ID: 30297743
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential.
Manten-Horst E; Danen EH; Smit L; Snoek M; Le Poole IC; Van Muijen GN; Pals ST; Ruiter DJ
Int J Cancer; 1995 Jun; 64(3):182-8. PubMed ID: 7542641
[TBL] [Abstract][Full Text] [Related]
17. O-linked glycosylation modifies CD44 adhesion to hyaluronate in colon carcinoma cells.
Dasgupta A; Takahashi K; Cutler M; Tanabe KK
Biochem Biophys Res Commun; 1996 Oct; 227(1):110-7. PubMed ID: 8858111
[TBL] [Abstract][Full Text] [Related]
18. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.
Jackson DG; Bell JI; Dickinson R; Timans J; Shields J; Whittle N
J Cell Biol; 1995 Feb; 128(4):673-85. PubMed ID: 7532175
[TBL] [Abstract][Full Text] [Related]
19. Kunitz-type protease inhibitor bikunin disrupts phorbol ester-induced oligomerization of CD44 variant isoforms containing epitope v9 and subsequently suppresses expression of urokinase-type plasminogen activator in human chondrosarcoma cells.
Suzuki M; Kobayashi H; Fujie M; Nishida T; Takigawa M; Kanayama N; Terao T
J Biol Chem; 2002 Mar; 277(10):8022-32. PubMed ID: 11777908
[TBL] [Abstract][Full Text] [Related]
20. Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer.
Karousou E; Misra S; Ghatak S; Dobra K; Götte M; Vigetti D; Passi A; Karamanos NK; Skandalis SS
Matrix Biol; 2017 May; 59():3-22. PubMed ID: 27746219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]